#Clinical trials3

28 Dec 2025

Lower chemotherapy dose helps people 80+ with lymphoma

A study found that people aged 80 and older with a common lymphoma often do better with a lower chemotherapy dose. Researchers used data from community cancer clinics and say the smaller dose kept effectiveness while reducing side effects.

Read

Photo by John Vid, Unsplash

17 Dec 2025

Most US drug trials do not mirror racial and ethnic diversity

A study of pivotal trials used to approve new drugs found only a small share reflect the United States racial and ethnic makeup. The review shows underrepresentation of Black and Hispanic people and urges more diversity earlier in development.

Level

Read

10 Dec 2025

Antibody therapy clears traces of multiple myeloma

A phase 2 trial found that an antibody drug, linvoseltamab, removed detectable disease in patients with multiple myeloma using very sensitive bone marrow tests. Researchers report acceptable safety and will expand the trial.

Level

Read

No more articles